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Abstract
Background: Segmented phase-sensitive inversion recovery (PSIR) cardiovascular magnetic resonance (CMR)
sequences are reference standard for non-invasive evaluation of myocardial fibrosis using late gadolinium
enhancement (LGE). Several multi-slice LGE sequences have been introduced for faster acquisition in patients with
arrhythmia and insufficient breathhold capability.
The aim of this study was to assess the accuracy of several multi-slice LGE sequences to detect and quantify
myocardial fibrosis in patients with ischemic and non-ischemic myocardial disease.
Methods: Patients with known or suspected LGE due to chronic infarction, inflammatory myocardial disease and
hypertrophic cardiomyopathy (HCM) were prospectively recruited. LGE images were acquired 10–20 min after
administration of 0.2 mmol/kg gadolinium-based contrast agent. Three different LGE sequences were acquired: a
segmented, single-slice/single-breath-hold fast low angle shot PSIR sequence (FLASH-PSIR), a multi-slice balanced
steady-state free precession inversion recovery sequence (bSSFP-IR) and a multi-slice bSSFP-PSIR sequence during
breathhold and free breathing. Image quality was evaluated with a 4-point scoring system. Contrast-to-noise ratios
(CNR) and acquisition time were evaluated. LGE was quantitatively assessed using a semi-automated threshold
method. Differences in size of fibrosis were analyzed using Bland-Altman analysis.
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Results: Three hundred twelve patients were enrolled (n = 212 chronic infarction, n = 47 inflammatory myocardial
disease, n = 53 HCM) Of which 201 patients (67,4%) had detectable LGE (n = 143 with chronic infarction, n = 27
with inflammatory heart disease and n = 31 with HCM). Image quality and CNR were best on multi-slice bSSFP-PSIR.
Acquisition times were significantly shorter for all multi-slice sequences (bSSFP-IR: 23.4 ± 7.2 s; bSSFP-PSIR: 21.9 ± 6.
4 s) as compared to FLASH-PSIR (361.5 ± 95.33 s). There was no significant difference of mean LGE size for all
sequences in all study groups (FLASH-PSIR: 8.96 ± 10.64 g; bSSFP-IR: 8.69 ± 10.75 g; bSSFP-PSIR: 9.05 ± 10.84 g;
bSSFP-PSIR free breathing: 8.85 ± 10.71 g, p > 0.05).
LGE size was not affected by arrhythmia or absence of breathhold on multi-slice LGE sequences.
Conclusions: Fast multi-slice and standard segmented LGE sequences are equivalent techniques for the assessment
of myocardial fibrosis, independent of an ischemic or non-ischemic etiology. Even in patients with arrhythmia and
insufficient breathhold capability, multi-slice sequences yield excellent image quality at significantly reduced scan
time and may be used as standard LGE approach.
Trial registration: ISRCTN48802295 (retrospectively registered).
Keywords: Cardiac MR, CMR, Late gadolinium enhancement, Single-shot, Hypertrophic cardiomyopathy, Myocardial
infarction, Inflammatory heart disease, Myocarditis
Background
Late gadolinium enhancement (LGE) cardiovascular
magnetic resonance (CMR) is a well-established method
for assessment of focal myocardial fibrosis and scarring
in ischemic and non-ischemic cardiomyopathies [1–4].
The presence and extent of LGE has been shown to be
associated with worse patient outcome in a variety of
diseases, i.e. myocardial infarction, hypertrophic cardio-
myopathy (HCM) and acute or chronic inflammatory
heart disease [5–7]. Hence, the assessment of LGE is in-
tegrated into many clinical guidelines and is an integral
part of most contrast-based CMR protocols [8–10].
The reference standard technique for LGE assessment
is typically based on phase-sensitive inversion recovery
(PSIR) sequences that are acquired in a single-slice,
single-breathhold fashion [11, 12]. These segmented
PSIR LGE images generate excellent image quality at a
high spatial resolution if the individual patient has suffi-
cient breathhold capabilities and is in sinus rhythm [13].
However, with the more widespread use of CMR in clin-
ical routine increasing numbers of patients referred for
CMR present with arrhythmias or an inability for sufficient
breathhold for CMR scan. In these patients, conservative
segmented PSIR LGE sequences sometimes fail to provide
satisfactory image quality for accurate assessment.
Furthermore, standard segmented LGE sequences typic-
ally require 5 to 10 min of scan time for complete myocar-
dial coverage. There is a need for faster and more efficient
imaging in CMR in order to enable a more wide-spread use
of CMR in clinical routine as well as in smaller institutions
where access to CMR scanners maybe more restricted [14].
CMR also competes with other non-invasive imaging tech-
niques in terms of scan time optimization leading to efforts
for faster standardized CMR scan protocols [15].
In order to address these issues, multi-slice LGE
sequences have been developed with acquisition of the
entire k-space of an individual image slice within one
heart cycle [16]. Different approaches utilize navigator-
based, free breathing sequencing which works without
breathhold but mostly still requires stable heart rhythm
for optimal image quality [17].
Several small clinical studies have shown that multi-slice
LGE sequences provide similar image quality to standard
segmented LGE sequences [18, 19]. However, the vast ma-
jority of these studies investigated only patients with a sin-
gle disease entity, i.e. myocardial infarction or HCM and/
or excluded patients with arrhythmia. Hence, these studies
are not reflecting clinical reality where the underlying
cause of LGE is often not known prior to the CMR scan
and sinus rhythm is often unstable or non-existent.
In this prospective study we intended to determine the
comparability of standard segmented PSIR LGE imaging
with two different multi-slice LGE sequences with and
without breathhold in a large number of patients with is-
chemic and non-ischemic cardiomyopathy, namely
chronic myocardial infarction, HCM and inflammatory
heart disease. Furthermore, we explicitly did not exclude
patients with arrhythmia. We aimed to assess if multi-
slice LGE sequences represent a robust alternative for
LGE assessment independent of pathophysiologic origin
of LGE, heart rhythm and patient breathhold capabilities.
Methods
Study population
312 consecutive patients with known or suspected LGE
were prospectively recruited. All patients were referred
for clinical LGE assessment using CMR for both, ische-
mic and non-ischemic cardiomyopathies, based on the
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clinical information provided by the referring cardiolo-
gist. A total of 212 patients had chronic myocardial in-
farction, 53 patients had HCM and 47 patients had
inflammatory heart disease.
All patients underwent a single CMR scan with three
different LGE sequences. Exclusion criteria were contra-
indications to CMR and severe chronic renal disease
with an estimated glomerular filtration rate < 30 ml/min/
1.73m2. All studies were performed in accordance with
the local institutional review board and local ethics
committee approval.
Image protocol
All CMR studies were performed on a 1.5 Tesla scanner
(AvantoFit®, Siemens Healthineers, Erlangen, Germany).
Patients were scanned with electrocardiogram (ECG)-
triggering in the supine position using 16-channel
surface phased array coils.
All imaging protocols included assessment of myocar-
dial function in balanced steady-state free precession
(bSSFP) cine sequences and of myocardial morphology
by LGE imaging.
bSSFP cine imaging (TE 1.19 ms, TR 33.36 ms, flip angle
55°, retrospective ECG-triggered gating, matrix
192x156mm, FOV 340 mm, slice thickness 6 mm, band-
width 930 Hz, 30 phases per heart cycle, iPAT GRAPPA
acceleration factor 2) was performed in long axis two- and
four-chamber view for biplanar assessment of left
ventricular (LV) end-diastolic volume (LVEDV), LV mass
(LVM) and LV ejection fraction (LVEF). Contours were
drawn manually and biplanar anatomical and functional
parameters calculated automatically by the post-
processing software according to an established in-line bi-
plane ellipsoid model. [20] The standard three-point
method was used on short axis localizers to define stan-
dardized long axis two-chamber (one point in the LV apex,
one point in the anterior and one point in the inferior wall
of the lv myocardium in the slice with the maximum LV
area) and four-chamber view (one point in the LV apex,
one point in the interatrial septum below the aorta and
one point into the most lateral corner of the right ven-
tricle (RV) on the short axis localizer with the maximum
RV area).
For LGE imaging, a 0.2 mmol/kg intravenous injection
of contrast agent was administered into an antecubital
vein. In patients with myocardial infarction or HCM as-
sessment gadoteridol (ProHance®, Bracco S.p.A., Milan,
Italy) was used. For patient with known or suspected in-
flammatory heart disease gadopentetate (Magnevist®,
Bayer Healthcare, Wayne, New Jersey, USA) was admin-
istered due to established normal values for this contrast
agent for the early enhancement technique which was
clinically assessed in these patients independently from
this study [21].
Ten minutes after contrast administration, a segmented
IR cine bSSFP inversion time (TI) scouting sequence was
performed at a mid-ventricular short axis location to de-
termine optimal TI [22]. TI was adapted to optimally null
the signal of the remote myocardium. Two-dimensional
LGE images were acquired in short-axis views covering
the entire LV myocardium by using three different LGE
sequences: i) a segmented, single-slice, single-breathhold
2D FLASH-based phase-sensitive inversion recovery se-
quence (FLASH-PSIR) which was considered as the refer-
ence standard; ii) a multi-slice 2D bSSFP-based inversion
recovery sequence (bSSFP-IR); iii) a multi-slice 2D bSSFP-
based PSIR sequence (bSSFP-PSIR).
Sequence details are displayed in Table 1.
All LGE sequences were acquired in end-expiratory
breathhold while the bSSFP-PSIR sequence was add-
itionally acquired in free breathing. In case of suspected
artifacts in the LGE images a second perpendicular slice
through the affected region was acquired or read-out of
the phase encoding direction was swapped. Segmented
and multi-slice LGE images were acquired in random
order. Acquisition times and occurrence of arrhythmia
during image acquisition were noted for all sequences.
Qualitative and quantitative image analysis
For all post-processing analyses commercially available
software was used (CVI42 Release 5.6.2, Circle Cardio-
vascular Imaging, Calgary, Canada). A blinded reader
performed LV function assessment in bSSFP cine long
axis slices. For assessment of LVEF endocardial contours
were drawn in the end-diastolic and end-systolic phase
of two- and four-chamber view. All parameters were
automatically calculated after contouring by the post-
processing software. Separately, image quality and
quantitative LGE assessment were performed in a
random and blinded order.
For 30 randomly selected individuals, the same reader
and a second experienced reader repeated analyses for
assessment of intra- and interobserver variability.
Image quality
Visual assessment of image quality was performed on all
LGE sequences for each patient using a previously estab-
lished 4-point-scale using the following grading: excellent
quality, no artifacts (score of 1); good quality, minimal ar-
tifacts (score of 2); moderate quality, some artifacts which
may impair diagnostic quality (score of 3); poor quality,
unacceptable artifacts (score of 4) [19].
Signal intensities were measured in regions of interest
(ROIs) that covered areas of contrast-enhanced myocar-
dium, as well as areas of remote non-enhanced myocar-
dium with an additional ROI located outside the patient
for calculation of background noise. Signal enhancement
was measured as recommended by Simonetti et al. [12].
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In detail, we calculated signal intensities and their
standard deviations in ROIs of LGE-positive myocar-
dium, as well as areas of remote myocardium. Contrast
was defined as difference between mean signal intensity
of both ROIs. Image noise was defined as the standard
deviation of the signal intensity in the normal-appearing
myocardium ROI. Contrast-to-noise ratios (CNR) were
calculated by using these values. Measurement of signal-
to-noise ratios (SNR) is limited on PSIR images conven-
tionally because the measurement of background noise
is invalid in the reconstructed images [23]. Therefore,
we did not perform SNR assessment.
Visual LGE assessment
The distribution area and transmurality of fibrosis was
evaluated according to the American Heart Association
(AHA) 16-segment model. The distribution area of scar
in each segment was scored by the proportion of scar to
each segment (0: no LGE, 1: 1–25%, 2: 26–50%, 3: 51–
75%, 4: 76–100%).
For each subject, the number of segments with
presence or absence of fibrosis and location within
the myocardial wall (subendocardial, intramural, sube-
picardial, transmural) was noted for each LGE
sequence as previously described [24].
Quantitative LGE assessment
Quantification of LGE was performed with the estab-
lished semi-automated signal threshold versus reference
mean (STRM) method as published previously by our
and other groups [21, 25, 26]. On all LGE images, endo-
cardial and epicardial contours were manually traced
and ROIs were defined in hyperenhanced and remote
myocardium.
True LGE was defined by myocardial signal intensity
plus 6 standard deviations (SD) above that of remote,
normal-appearing myocardium within the same slice in
patients with myocardial infarction. For subjects with
HCM and inflammatory heart disease, plus 3 SDs were
defined as true LGE [27].
The automated LGE detection could be manually cor-
rected by the reader for a specific location to exclude
obvious artifacts. After segmentation, myocardial and
scar tissue mass (in grams) were calculated and com-
pared for each AHA segment in each sequence.
Statistical analysis
All statistical analyses were conducted by using statis-
tical software package SPSS 17.0 (International Business
Machines, Armonk, New York, USA). Quantitative data
are expressed as means ± SD. Sample size was calculated
by using power analysis for two proportions to reach a
statistical power of more than 80% to detect differences
of 5%, using the assumption of 16 ± 12 g scar tissue for
patients with chronic myocardial infarction, and 9 ± 5 g
for HCM and inflammatory heart disease which were re-
ported previously by our group [26].
Image quality scores were compared by using the
Mann-Whitney U test. Interobserver and intraobserver
agreement was assessed by using Cohen k statistics.
Statistical comparison of means of LGE size in each
individual multi-slice technique against the segmented
reference standard technique was performed by using
two-tailed paired t tests and Bland-Altman analysis. Scar
tissue percentages per segment, CNR and signal en-
hancement ratios were assessed using the Wilcoxon
signed rank test, as these values did not show normal
distribution.
Results
Patient characteristics
In total, 312 patients were recruited. Fourteen of these
patients were excluded due to incomplete image acquisi-
tion. All remaining 298 patients were successfully
scanned using all techniques and were included in sub-
sequent analyses (203 patients with chronic myocardial
infarction, 50 patients with HCM and 45 patients with
inflammatory heart disease). Patient characteristics are
shown in Table 2. Study individuals with inflammatory
heart disease were significantly younger than patients in
the other groups. HCM patients had an increased LVM
index (LVM-I), decreased LVEDV index (LVEDV-I) and
a slightly elevated LVEF. Figure 1 shows representative
images of LGE short axis slices for each group and each
sequence.
Acquisition time
The average scan time was significantly longer for the
reference standard sequence (361.5 ± 95.3 s including
breaks between slice acquisitions) than for any multi-
slice sequence (SSFP-IR: 23.4 ± 7.2 s; SSFP-PSIR: 21.9 ±
6.4 s, p < 0.01 of all sequences against reference
standard).
Table 1 LGE sequence parameters
FLASH-PSIR SSFP-IR SSFP-PSIR
Mode Segmented Multi-slice
(single shot)
Multi-slice
(single shot)
TE [ms] 5.17 1.06 1.05
Flip Angle 30° 50° 65°
Field of view [mm] 350–450 350–450 350–450
Matrix [mm] 192 × 256 154 × 192 144 × 192
Slice thickness [mm] 7 7 7
Slice gap [mm] 0 0 0
TE Echo time
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Image quality assessment
Image quality scores differed significantly between each
multi-slice and the reference standard sequence. How-
ever, they were not influenced by disease entity or – re-
garding bSSFP-PSIR sequence – breathhold versus free
breathing acquisition. Overall, bSSFP-PSIR images
showed the best image quality scores. (Fig. 2).
Arrhythmia had a negative impact on image quality
scores on the segmented FLASH-PSIR sequence, result-
ing in poor or non-diagnostic image quality in 48,8% of
all patients. Image quality score was not influenced by
arrhythmia in any multi-slice sequence.
Assessment of infarcted-to-remote area CNR is shown
in Table 3. Mean infarcted-to-remote myocardium CNR
was significantly higher on bSSFP-PSIR than on refer-
ence standard sequences (p < 0.01), and on bSSFP-IR
lower than reference standard (p < 0.01). Free breathing
acquisition of bSSFP-PSIR slightly decreased mean
infarcted-to-remote area CNR as compared to acquisi-
tion under breathhold, however, was still superior to ref-
erence standard (p < 0.01). LGE due to chronic
infarction showed significantly higher CNR values in all
sequences than LGE due to HCM or inflammatory heart
disease (p < 0.01).
Table 2 Patient Characteristics
Chronic myocardial infarction HCM Inflammatory heart disease
Number of patients 203 50 45
Gender [♂ / ♀] 160 / 43 (78% / 22%) 35 / 15 (72% / 28%) 32 / 13 (71% / 29%)
Age [years] 66.2 ± 10.7 62.0 ± 14.5 46.3 ± 15.4 *
BMI [kg/m2] 27.6 ± 4.2 27.9 ± 4.3 25.8 ± 4.8
HR [min-1] 68.1 ± 11.5 69.8 ± 16.2 72.2 ± 12.9
LVEF [%] 52.9 ± 10.7 63.0 ± 10.9 * 52.6 ± 13.3
LVEDV-I [ml/m2] 82.5 ± 24.3 69.6 ± 22.1 * 90.9 ± 26.9
SV-I [ml/m2] 41.9 ± 8.7 43.3 ± 12.6 44.8 ± 8.9
LVM-I [g/m2] 59.3 ± 15.8 89.5 ± 28.4 * 61.9 ± 17.2
SR / Arrhythmia 166 / 37 (82% / 18%) 39 / 11 (78% / 22%) 38 / 7 (84% / 16%)
LGE detected [yes / no] 176 / 27 (87% / 13%) 39 / 11 (78% / 22%) 32 / 13 (71% / 29%)
HCM Hypertrophic cardiomyopathy; BMI Body mass index; HR Heart rate; LVEF Left ventricular ejection fraction; LVEDV-I Left ventricular end-diastolic volume index;
SV-I Stroke volume index; LVM-I Left ventricular mass index. SR Sinus rhythm. * p < 0.05
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Fig. 1 Representative LGE images. Three selected patients with chronic myocardial infarction (a-d), hypertrophic cardiomyopathy (e-h) and acute
myocarditis (i-l) with typical LGE localization: subendocardial for infarction, patchy intramural for HCM and subepicardial for myocarditis.
Horizontal rows display corresponding slices of LGE in the same patient, vertical columns show the used techniques: conventional segmented
FLASH-PSIR (a;e;i), multi-slice bSSFP-IR (b;f;j), multi-slice bSSFP-PSIR with breathhold (c;g;k) and free-breathing multi-slice bSSFP-IR
(d;h;l). nonbh = non-breathhold
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Qualitative LGE analysis
Using reference standard sequence, 201 patients (67.4%)
had detectable LGE (n = 143 with chronic infarction,
n = 31 with HCM and n = 27 with inflammatory heart
disease). All 201 LGE-positive patients also had detect-
able LGE on bSSFP-IR. With both bSSFP-PSIR se-
quences, two small LGE lesions (< 1 g scar size) were
visually not detected in one patient with chronic infarc-
tion and one patient with HCM by two blinded readers.
On visual assessment, circumferential extent of scars
was similar in all sequences; summation of scores
showed excellent matching with reference standard
FLASH-PSIR sequence (total score 3875) for bSSFP-
PSIR with (total score 3903) and without breathhold
(total score 3886) while on bSSFP-IR circumferential
scar extent was slightly underestimated (total score
3726). Details are shown in Fig. 3a.
On all multi-slice sequences, the visual allocation of
LGE within the myocardial wall (subendocardial, subepi-
cardial, intramural, transmural) showed good matching
with FLASH-PSIR for the chronic infarction and inflam-
matory heart disease group while for inflammatory heart
disease there was a higher number of visually transmural
LGE areas on bSSFP-PSIR versus FLASH-PSIR (14%
versus 10% segments with transmural LGE, see Fig. 3b).
Quantitative LGE analysis
There were no significant differences in mean LGE size
between reference standard FLASH-PSIR and multi-slice
sequences independent from LGE origin (Table 4). How-
ever, Bland-Altman analysis showed that on bSSFP-PSIR
LGE size showed a non-significant trend to be smaller in
all study groups compared to reference standard - mean
difference in LGE size towards reference standard being
0.58 ± 1.99 g on bSSFP-PSIR with breathhold, 0.96 ±
2.03 g on bSSFP-PSIR with free breathing and 0.26 ±
2.4 g on bSSFP-IR (see Fig. 4 for Bland-Altman plots).
The presence or absence of breathhold during LGE
imaging using bSSFP-PSIR had no impact on LGE size
for any disease entity (Table 4).
Intraobserver agreement (Pearson coefficient) on LGE
size was > 0.95 for all sequences. Interobserver agree-
ment was 0.92 for bSSFP-PSIR under free breathing and
0.88 for all other sequences.
In patients with arrhythmia during image acquisition
mean LGE size did not differ in any multi-slice se-
quence, with bSSFP-IR 7.6 ± 6.1 g and bSSFP-PSIR 7.7 ±
5.6 g under breathhold and 7.4 ± 5.6 g under free breath-
ing. Reference standard FLASH-PSIR sequence was not
evaluated in arrhythmic patients due to mostly non-
diagnostic image quality.
Discussion
The present study compared for the first time a refer-
ence standard segmented (FLASH-PSIR) with two
multi-slice LGE sequences (bSSFP-IR and bSSFP-PSIR)
in 298 patients with ischemic and non-ischemic
cardiomyopathies.
Fig. 2 Image quality scores. Values represent average image quality score for all patients in each group. Score system: 1 = excellent quality, no
artifacts; 2 = good quality, minimal artifacts; 3 = moderate quality, some artifacts which may impair diagnostic quality; 4 = poor quality,
unacceptable artifacts. * p < 0.05 within sequence. ** p < 0.05 towards FLASH-PSIR. ns = non-significant, p > 0.05. SR = sinus rhythm
Table 3 Contrast-to-noise ratios
All groups Chronic infarction HCM Inflammatory heart disease
FLASH-PSIR 65.9 ± 71.9 67.9 ± 58.5 * 80.4 ± 126.8 37.0 ± 21.3 *
SSFP-IR 40.1 ± 26.8† 43.2 ± 28.4 *† 38.5 ± 19.9 † 31.5 ± 22.2†
SSFP-PSIR 137.8 ± 103.7† 149.8 ± 114.9 *† 118.4 ± 66.9† 95.7 ± 49.2 *†
SSFP-PSIR nonbh 125.9 ± 72.5† 134.5 ± 72.5 *† 101.7 ± 65.8† 109.0 ± 73.4 †
*p < 0.05 towards the other disease entities for the individual LGE sequence. † p < 0.05 towards FLASH-PSIR gold standard for individual disease entity
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Our key findings were: Firstly, image quality and CNR
were highest on multi-slice bSSFP-PSIR with and with-
out breathhold. Secondly, acquisition time is relevantly
shorter on any multi-slice sequence compared to refer-
ence standard. Thirdly, visual detection of LGE and vis-
ual assessment of LGE extent was consistently very good
and equivalent in all sequences. Fourthly, quantification
showed no significant difference in LGE size for any
multi-slice sequence. Fifthly, in patients with arrhythmia
all multi-slice sequences generated good image quality
and consistent LGE quantification results, whereas the
reference standard provided non-diagnostic image qual-
ity in half of all exams. Finally, acquisition of bSSFP-
PSIR under free breathing or under breathhold had no
impact on LGE detection and quantification. Results
were independent of the cause of LGE from ischemic or
non-ischemic etiology.
The assessment of myocardial fibrosis has enormous
diagnostic and prognostic impact in ischemic and non-
ischemic cardiomyopathy [5–7]. Over the last decade
a
b
Fig. 3 Visual assessment of LGE. a: Visual assessment of circumferential LGE extent. Columns represent number of segments with LGE for
different circumferential extents across all study groups (chronic myocardial infarctions, HCM, inflammatory heart disease). b: Visual assessment of
in-wall LGE location
Table 4 Quantitative Assessment - LGE size
All groups Chronic infarction HCM Inflammatory heart disease
FLASH-PSIR 8.96 ± 10.64 g 7.47 ± 6.65 g 15.42 ± 20.00 g 9.39 ± 10.28 g
SSFP-IR 8.69 ± 10.75 g 7.26 ± 7.03 g 15.31 ± 20.02 g 8.67 ± 9.66 g p > 0.05
SSFP-PSIR 9.05 ± 10.84 g 7.68 ± 7.18 g 15.51 ± 20.31 g 8.89 ± 9.30 g p > 0.05
SSFP-PSIR nonbh 8.85 ± 10.71 g 7.41 ± 6.91 g 15.38 ± 19.96 g 8.97 ± 9.94 g p > 0.05
Values represent mean LGE size in gram. P values for each multi-slice sequence compared to FLASH-PSIR in all study groups
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many clinical studies have paved the way for CMR to be
integrated into a variety of cardiologic, radiologic and
other clinical guidelines [9]. The role of LGE in detec-
tion of myocardial fibrosis remains unequivocally im-
portant despite the development of new parametric
mapping techniques, which play an increasing role
especially in detection of diffuse fibrosis [28, 29].
Our study demonstrates that bSSFP-PSIR and bSSFP-
IR multi-slice LGE sequences provide excellent alterna-
tives to segmented FLASH-PSIR in routine CMR proto-
cols. We showed that not only for ischemic LGE lesions
but also for more diffuse lesions in inflammatory heart
disease or HCM multi-slice sequences are sufficient to
visualize fibrosis and – when quantified in size – show
equivalent results compared to the reference standard.
The equivalence of multi-slice LGE sequences to seg-
mented sequences has previously been shown in studies
for either HCM, ischemic or inflammatory heart disease
[18, 19, 30]. However, these studies each used different
sequences, smaller patient groups and mostly looked at
single disease entities.
The superiority of multi-slice over segmented PSIR
sequences in regard to image quality and CNR is in line
with other publications [18, 19]. This is attributable to
the reduction of motion artifacts and artifacts due to
arrhythmia. CNR also depends on the amount of
gadolinium-based contrast media in the myocardium,
which is influenced by amount and molarity of contrast
agent, distribution volume and hemodynamics. As we
strictly dosed gadolinium to body weight and tested
sequences in a random order, effects on results should
be neglectable.
We have also seen variations in CNR between the
different disease entities. Since CNR is dependent on
the voxel composition of fibrotic tissue, LGE in
chronic infarction with more compact fibrosis is ex-
pected to result in higher CNR values than LGE in
more diffusely fibrotic tissue such as in HCM and in-
flammatory heart disease.
On bSSFP-PSIR sequence visual assessment revealed
slightly larger scar transmurality as compared to the ref-
erence standard. We believe that visual assessment of
bSSFP-PSIR images is impacted by its comparably higher
CNR values which may lead to subjectively higher trans-
murality of scars.
In two patients, small LGE lesions detectable with the
reference standard sequence, were not detected with
multi-slice bSSFP-PSIR but, nevertheless, could be visu-
alized with bSSFP-IR. Note that for these two patients
LGE amount was less than one gram, which suggests
that partial volume effects or shifted slice position due
to heavy respiratory motion may have caused the missed
lesion. However, it cannot be safely excluded that very
small LGE lesions may be missed with multi-slice
bSSFP-PSIR due to its different matrix size as compared
to the reference standard.
It has been shown that even a small amount of
LGE has prognostic implications in cardiomyopathies
[31–34]. In case of inflammatory heart disease missed
small subepicardial LGE may even impact diagnosis
[35], as Lake Louise criteria define myocarditis as two
out of three parameters, LGE being one of them [36].
Our results suggest that in patients with known or
suspected myocardial infarction bSSFP-PSIR or bSSFP-
IR multi-slice sequences can be primarily utilized for
LGE detection. In case of an unknown cardiomyopathy
or for assessment of HCM and inflammatory heart dis-
ease segmented FLASH-PSIR images should be used in
scenarios of stable sinus rhythm and sufficient breath-
hold capabilities. For patients with arrhythmia and/or in-
sufficient breathhold capabilities at the time of CMR
scan we showed that segmented sequences fail to pro-
vide sufficient image quality. This is in line with previous
studies [37, 38]. In these patients we suggest to primarily
use multi-slice sequences such as bSSFP-PSIR and/or
bSSFP-IR.
In this study two different contrast media were
used; gadoteridol in CAD and HCM patients and
Fig. 4 Bland-Altman plots of LGE mass. Blue dots represent mean LGE size (x-axis) versus delta LGE mass towards FLASH-PSIR (y-axis) in gram for
each LGE sequence
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gadopentate for inflammatory heart disease. The rea-
son for use of gadopentate was established normal
values for relative enhancement sequences, which
were acquired in these patients independently from
this study. However, there is good evidence that
relaxivity and contrast enhancement are nearly identi-
cal for both agents so that impact on results should
be neglectable. [39]
In our study we explicitly did not exclude patients
with arrhythmia. We demonstrated good to excellent
image quality and equivalent amount of LGE quantifica-
tion with all multi-slice sequences. There is no gold
standard for LGE detection and quantification in
arrhythmic patients. Hence, we cannot definitely state
that results are perfectly correct using multi-slice se-
quences. Still, due to the consistently high image quality
scores and – as compared to patients with sinus rhythm
– similar CNR values we feel confident that usage of any
multi-slice sequence is superior to attempts of seg-
mented image acquisition and shortens scan protocols
significantly in these patients.
Interestingly, presence or absence of breathhold
during image acquisition on bSSFP-PSIR did not
affect detection or quantification of LGE across all
study groups. While there must be minimal slice
shifting due to respiratory motion on acquisition of
an entire LV short axis package within approximately
20 s of acquisition time we could show in a large
number of patients that this has no statistically sig-
nificant effect on diagnostic value. Lower numbers of
breathhold cycles may also positively affect patient
comfort and may be considered in all patients when
SSFP-PSIR sequence is used.
Alternative methods for LGE assessment include 3D
sequences, which have been shown to also accurately
visualize fibrosis and scarring [40, 41]. These 3D se-
quences have the advantage of potentially higher spatial
resolution, especially in the vertical axis, and the possi-
bility of free movement through the ventricular myocar-
dium. On the other hand, 3D sequences typically require
a relatively long acquisition time. This necessitates a
continuous adaptation of the optimal myocardial inver-
sion time, which may impair image quality and CNR.
Implementation of 3D LGE sequences with dynamic in-
version time adjustments may help to overcome this
obstacle [42].
In another recent study dark blood PSIR imaging
was published using T2 preparation pulses for im-
proved visualization of fibrosis close to the adjacent
LV blood pool in 30 patients with subendocardial in-
farction [43]. This promising technique also included
motion correction for acquisition under free breathing
but needs to be validated across myocardial disease
entities in larger studies.
Conclusions
LGE sequences are a mandatory part of most CMR pro-
tocols in ischemic and non-ischemic cardiomyopathy
[8]. The broader spread of CMR in clinical routine has
several implications: demand for CMR access increases
and there is a continuous need for fast scanning proto-
cols [14]. While segmented LGE sequences may give
excellent image quality under stable sinus rhythm and
sufficient breathhold the issue of time investment pre-
vails. We demonstrated equivalence of multi-slice LGE
sequences (bSSFP-IR and bSSFP-PSIR) and segmented
FLASH-PSIR sequence in a large number of patients
with ischemic and non-ischemic cardiac disease.
For that reason we suggest further strengthening the
role of multi-slice sequences in routine CMR protocols
whenever it is reliable to use.
Limitations
In spite of the large patient number in this study, all pa-
tients were scanned and analyzed in a single CMR center.
Male gender was overrepresented in all study groups.
Comparability of LGE sequences maybe impacted by dif-
ferent matrix size and, hence, different in-plane resolution
used for each sequence. This may also affect SNR and
CNR as well as assessment of LGE-positive areas.
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